Osteo Arthritis of the Knee study: Lex Dexterity Trainer vs Wobble Board
Official title Home-Based Leg Dexterity Trainer for Management of Knee Osteoarthritis
ClinicalTrials.gov ID: NCT07397806
What this study is testing
- What it's testing
- This study aims to find out if using a specific leg dexterity trainer at home is better than using a wobble board for reducing pain and improving daily function.
- Who it's for
- The study is looking for adults who have knee osteoarthritis (wear-and-tear arthritis of the knee).
- What's involved
- Participants will use a portable device at home that requires them to stabilize a spring with their foot while seated. They will also use a tablet to track their progress and receive feedback.
- Time commitment
- The study lasts for 8 weeks and involves using the device at home as directed.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 85
You may be able to join if
- Age 40 to 85 years
- Ambulatory in home and community settings
- History of knee osteoarthritis in one or both knees (Kellgren-Lawrence grade II-IV)
- Baseline pain of 3-10 points on the target (i.e., more-affected) knee and a pain differential of at least -2 points on the contralateral knee as...
- Capacity to personally give informed consent (consent via a legally authorized representative will not be accepted) and who are willing to comply...
You likely can't join if
- Planned surgery on either the contralateral or target knee at any time during the Study period, including pre-and post-training assessments.
- Within 6 months of signing informed consent has received diagnostic arthroscopy of the target knee or arthroscopic surgery (including microfracture...
- Within 12 weeks of signing informed consent has received intra-articular treatment of the target knee with steroids or hyaluronic acid derivatives;
- Planned intra-articular treatment of the target knee with steroids or hyaluronic acid derivatives on either the contralateral or target knee at any...
- History of previous total or partial arthroplasty in the target knee.
- Within 2 years of signing informed consent, history of active blood disorders (i.e., DVTs, chronic blood clotting, hemophilia, leukemia, myeloma...
See the full eligibility criteria
- Age 40 to 85 years
- Ambulatory in home and community settings
- History of knee osteoarthritis in one or both knees (Kellgren-Lawrence grade II-IV)
- Baseline pain of 3-10 points on the target (i.e., more-affected) knee and a pain differential of at least -2 points on the contralateral knee as exhibited by the worst pain score for the previous week (on the 11-point...
- Capacity to personally give informed consent (consent via a legally authorized representative will not be accepted) and who are willing to comply with all study-related procedures and assessments
- Planned surgery on either the contralateral or target knee at any time during the Study period, including pre-and post-training assessments.
- Within 6 months of signing informed consent has received diagnostic arthroscopy of the target knee or arthroscopic surgery (including microfracture and meniscectomy) on the target knee;
- Within 12 weeks of signing informed consent has received intra-articular treatment of the target knee with steroids or hyaluronic acid derivatives;
- Planned intra-articular treatment of the target knee with steroids or hyaluronic acid derivatives on either the contralateral or target knee at any time during the Study period including pre-and post-training...
- History of previous total or partial arthroplasty in the target knee. Partial or total arthroplasty in the contralateral knee is acceptable as long as the surgery was performed at least 6 months prior to enrollment and...
- Within 2 years of signing informed consent, history of active blood disorders (i.e., DVTs, chronic blood clotting, hemophilia, leukemia, myeloma, etc.)
- Current diagnosis of fibromyalgia based on American College of Rheumatology (ACR) criteria.
- Any active known or suspected systemic autoimmune disease (except for vitiligo, residual auto-immune hypothyroidism requiring hormone replacement only, psoriasis not requiring systemic treatment for two years...
- Current or prior history of other joint diseases including but not limited to joint dysplasia, crystal-induced arthropathy (such as gout, or calcium pyrophosphate deposition disease evidenced by clinical and/or...
- Any medical condition, including findings in laboratory or medical history or in the baseline assessments, that (in the opinion of the Principal Investigator or his designee) constitutes a risk or contraindication for...
- Within 8 weeks of signing informed consent, has used opioid analgesics and is not willing to discontinue these medications through the duration of the study.
The study team makes the final eligibility decision.
Where it is enrolling
- Vail, Colorado, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Vail, Colorado, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.